Roche, Ainnova, and Salud 360 signed this alliance to improve access to vision screening in patients with uncontrolled diabetes.

Abstract: Diabetic retinopathy (DR) affects human vision, either directly or indirectly. Although it affects the focal length in its early stages, it could lead to loss of vision, over time.

The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched ...

Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular degeneration (AMD).

Diabetic retinopathy is the number one preventable cause of blindness. To avoid it, simply take care of your diabetes. Two ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...

KPJ Healthcare Berhad (“KPJ Healthcare” or “the Group”) is advancing healthcare transformation for its hospitals with the launch of the ‘Year of AInnovation’ campaign to elevate the integration of ...

Aster Hospital Al Qusais, recognized in Newsweek's“World's Best Smart Hospitals 2025” List among 350 hospitals globally and ...

The programme extends across community health centres, taluk hospitals, and district hospitals, making comprehensive eye care ...

Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new ...